Ares Management
ARCC
$18.41
-1.66%
Ares Capital Corporation is the largest publicly traded business development company (BDC) in the United States, investing primarily in first lien senior secured loans, unitranche facilities, second lien debt, subordinated loans, and select preferred and common equity of middle-market companies, operating within the asset management and private credit industry. As a scale leader with roughly $14 billion in market capitalization and a portfolio spanning hundreds of sponsor-backed borrowers, Ares Capital functions as a core holding for income investors seeking floating-rate credit exposure rather than as a niche or speculative lender. The current investor narrative is dominated by a tug-of-war between an 8.9% dividend yield and a deteriorating rate backdrop: falling short-term rates are compressing net investment income across the BDC sector, with peer Blue Owl already cutting its base dividend, while headlines warn of credit stress in private credit and the possibility that a future Fed rate hike under Chair Kevin Warsh could paradoxically benefit floating-rate lenders. Management's recent results showed a sharp sequential revenue jump and a 32.6% year-over-year top-line increase, but earnings quality and net asset value stability remain the central debate as investors weigh the durability of the payout against a 97.3% payout ratio and a stock trading below book value.…
ARCC
Ares Management
$18.41
Related headlines
ARCC 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ares Management's 12-month outlook, with a consensus price target around $20.77 and implied upside of +12.8% versus the current price.
Average Target
$20.77
0 analysts
Implied Upside
+12.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$19 - $23
Analyst target range
Coverage is solid, with 13 analysts and a consensus recommendation of Buy (mean rating 1.71 on a 1-to-5 scale where lower is more bullish). The average target price is $20.77, implying roughly 11% upside from the current $18.72, and the consensus leans bullish despite the stock's weak price action — a classic setup where analysts see value in the yield while the market votes with its feet. Estimated EPS averages $1.86 (range $1.81 to $1.92) on average revenue of $3.15 billion, which frames the forward PE of 9.68x as reasonable if those estimates hold. The target range runs from a low of $19.00 to a high of $23.00, a spread of about 21% around the average. The high target of $23.00 implies roughly 23% upside and would require either multiple expansion back toward book value or a stabilization of net investment income as rate cuts are absorbed; the low target of $19.00 implies only about 1.5% upside and effectively prices in flat-to-declining earnings with the dividend held but no re-rating. Institutional ratings show a mild negative drift — Wells Fargo downgraded to Equal Weight from Overweight in June 2026, while UBS remains Neutral and Truist, KBW, JPMorgan, RBC, and Citizens maintain Buy/Outperform — suggesting conviction is intact but enthusiasm is fading. The moderate spread between targets signals reasonable but not high conviction, and the recent downgrade pattern argues for patience until credit quality and dividend coverage show clearer signs of stabilization.
Drowning in data?
Find the real signal!
Bulls vs Bears: ARCC Investment Factors
The bear case currently carries stronger evidence: earnings are visibly compressing (net income down from $404 million in Q3 2025 to $171 million in Q2 2026), the payout ratio is 97.3%, and the stock has underperformed SPY by roughly 20 percentage points YTD. The bull case rests on valuation and income — 0.99x book, an 8.94% yield, and an 11% analyst target upside — which is real but is compensation for risk rather than a catalyst. The single most important tension is dividend coverage: if net investment income stabilizes enough to cover the payout, the 0.99x book discount closes toward the $20.77 consensus target; if it does not, a Blue Owl-style cut would likely break the $17.40 52-week low. Everything else — rate direction, credit losses, NAV marks — feeds into that one question.
Bullish
- 8.9% yield at 0.99x book: ARCC pays an 8.94% dividend yield while trading at just 0.99x price-to-book, meaning investors collect a near-9% cash yield while buying the loan portfolio at roughly net asset value. The P/B has drifted from 1.09x in Q2 2025 to 0.99x today, so the market is charging a modest discount for a portfolio that has historically been conservatively marked.
- Analyst consensus Buy with 11% upside: 13 analysts carry a mean rating of 1.71 (Buy) with an average target of $20.77, implying about 11% upside from $18.72. Even the low target of $19.00 sits above the current price, and the high target of $23.00 implies roughly 23% upside, showing the sell-side sees the current level as a value entry rather than a value trap.
- Revenue up 32.6% year over year: Q2 2026 revenue of $768 million rose 32.6% from $579 million in Q2 2025 and rebounded sharply from the $349 million trough in Q1 2026. Portfolio purchases of $3.02 billion matched sales and maturities of $3.02 billion, showing the book is actively turning over and being redeployed rather than shrinking.
- Low beta of 0.66 and floating-rate hedge: A beta of 0.66 means ARCC is roughly 34% less volatile than the market, and its floating-rate loan book means a Fed hike under Chair Kevin Warsh would lift asset yields and net investment income. That gives the position a genuine diversifying role versus a 15.53% one-year SPY gain that ARCC has not participated in.
Bearish
- 97.3% payout ratio leaves no cushion: Dividends paid of $345 million in Q2 2026 exceeded net income of $171 million, and the payout ratio stands at 97.3%. With net margin collapsing from 54.3% in Q4 2025 to 22.3% in Q2 2026, any further earnings compression forces a dividend cut — exactly what peer Blue Owl already did by trimming its base dividend to $0.31.
- Earnings quality deteriorating sharply: Net income fell from $404 million in Q3 2025 to $293 million in Q4 2025, $92 million in Q1 2026, and $171 million in Q2 2026, while EPS dropped from $0.57 to $0.24 over the same span. The Q2 2026 income statement also shows $391 million of net other expenses, meaning headline operating income of $581 million is being heavily eroded below the line.
- Severe relative underperformance: ARCC is down 8.41% YTD and 4.15% over one year while SPY is up 11.93% and 15.53%, producing relative strength of -20.34% YTD and -19.68% over one year. The stock sits at only 35% of its 52-week range ($17.40-$21.14) and is down 3.36% over the past month, with the decline accelerating.
- Falling rates compress net investment income: The entire BDC sector is being squeezed as short-term rates fall, and ARCC's sequential net income decline from $293 million to $92 million to $171 million tracks that compression. The forward PE of 9.68x versus trailing 10.88x implies only about 11% earnings growth, a thin cushion if asset yields keep falling faster than funding costs.
ARCC Technical Analysis
Ares Capital is in a mild, range-bound downtrend rather than a clean directional move. The stock is down 4.15% over the past year and 8.41% year-to-date, and at $18.72 it sits at roughly 35% of its 52-week range of $17.40 to $21.14 — closer to the floor than the ceiling, which signals persistent distribution pressure rather than momentum-driven overextension. That positioning means buyers are being paid a high yield to absorb a falling-knife risk, but it also leaves limited downside cushion before the 52-week low is retested. Recent momentum has deteriorated: the stock is down 3.36% over the past month and 2.35% over three months, and the 1-month decline is accelerating relative to the 3-month trend, a bearish short-term signal. The divergence versus the broader market is stark — SPY is up 1.22% over one month and 15.53% over one year, producing relative strength of -4.58% and -19.68% respectively — confirming that capital is rotating away from this name even as the tape holds up. The most recent price action (a slide from $19.16 on October 1 to $18.72 on October 16) reinforces the deceleration, and with no RSI provided, the price pattern alone suggests sellers remain in control near-term. Key support sits at the 52-week low of $17.40, roughly 7% below the current price; a breakdown there would likely trigger yield-driven capitulation and open a deeper move. Resistance is the 52-week high of $21.14, about 13% above spot, and a breakout above that level would signal a full trend reversal and renewed confidence in the dividend. The beta of 0.66 indicates the stock is roughly 34% less volatile than the market, which supports a lower-risk position sizing but also explains why it has lagged a rising market so severely; the 22.1% maximum drawdown underscores that low beta has not insulated holders from meaningful capital loss.
Beta
0.66
0.66x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$17-$21
Price range past year
Annual Return
-5.6%
Cumulative gain past year
| Period | ARCC Return | S&P 500 |
|---|---|---|
| 1m | -5.1% | +0.6% |
| 3m | -2.8% | +2.4% |
| 6m | -3.6% | +7.8% |
| 1y | -5.6% | +15.4% |
| ytd | -9.9% | +12.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ARCC Fundamental Analysis
Revenue has been volatile but is trending higher on a year-over-year basis. The most recent quarter (Q2 2026, ended June 30) delivered $768 million in revenue, up 32.6% year-over-year from $579 million in Q2 2025, and a sharp rebound from the $349 million reported in Q1 2026. The multi-quarter pattern is choppy — Q3 2025 was $655 million, Q4 2025 $540 million, Q1 2026 $349 million — reflecting the lumpy nature of investment income and realized gains rather than a smooth compounding trajectory, so the headline growth rate overstates the underlying run-rate stability. The investment case therefore hinges less on revenue growth and more on portfolio yield and credit quality, which the segment data does not break out. Profitability is solid but compressing at the margin. Q2 2026 net income was $171 million on a 77.5% gross margin and a 22.3% net margin, down meaningfully from the 54.3% net margin in Q4 2025 and the 61.7% in Q3 2025, while the trailing net margin of 57.9% and operating margin of 62.4% still reflect the structural economics of a lender earning a spread over its cost of funds. The sequential decline in net income from $293 million in Q4 2025 to $92 million in Q1 2026 and $171 million in Q2 2026 shows earnings are being squeezed, consistent with falling rates reducing asset yields faster than funding costs. Balance sheet leverage is elevated but typical for the sector: debt-to-equity is 1.12x, the current ratio is 1.71, and free cash flow TTM is $1.06 billion against quarterly operating cash flow of $336 million. The company is funding growth internally and through portfolio turnover — Q2 purchases of investments were $3.02 billion against $3.02 billion of sales and maturities — but dividends paid of $345 million exceeded net income of $171 million, and the 97.3% payout ratio leaves little margin for error. ROE of 9.07% and ROA of 4.94% are respectable for a levered credit vehicle but offer a thin buffer against credit losses.
Quarterly Revenue
$768000000.0B
2026-06
Revenue YoY Growth
+32.6%
YoY Comparison
Gross Margin
77.5%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ARCC Overvalued?
Because net income is positive, the PE ratio is the primary metric, and the picture is bifurcated. The trailing PE of 10.88x versus a forward PE of 9.68x implies the market expects earnings to grow modestly, but the gap is narrow — only about 11% — suggesting limited optimism about earnings acceleration. The PEG ratio of -0.46 is not meaningful given the sign of the growth input, and the price-to-book of 0.99x is the more telling anchor: the stock trades at a slight discount to net asset value, a classic signal that investors are pricing in credit risk or dividend risk. Against the asset management industry, the stock screens cheap on earnings but expensive on sales. The PS ratio of 6.31x and EV/sales of 9.35x are high for a lender, while EV/EBITDA of 20.89x reflects the accounting treatment of investment income rather than operating cash generation. The 8.94% dividend yield is the dominant valuation lever and sits well above the sector's typical yield, which is precisely why the market demands a discount to book — the yield is compensating for perceived risk rather than reflecting a free lunch. Historically, the stock has traded in a wide PE band. The trailing PE of 10.88x compares with 19.30x in Q2 2026, 34.65x in Q1 2026, 12.34x in Q4 2025, and 8.95x in Q3 2025, while the price-to-book has drifted from 1.09x in Q2 2025 to 0.99x today. The current multiple sits in the lower half of its own range, consistent with either a value opportunity or a market pricing in fundamental deterioration — and given the falling-rate and credit-stress narrative, the latter interpretation carries more weight until NAV stability is proven.
PE
10.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 5x~20x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on dividend coverage and earnings volatility. The payout ratio is 97.3%, and Q2 2026 dividends of $345 million exceeded net income of $171 million, so the dividend is currently being funded partly from portfolio turnover rather than earnings. Net margin has fallen from 54.3% in Q4 2025 to 22.3% in Q2 2026, and quarterly EPS has dropped from $0.57 to $0.24 over the same period, while debt-to-equity of 1.12x means a modest decline in asset values is magnified for equity holders. Revenue is also lumpy — $655 million, $540 million, $349 million, then $768 million across the last four quarters — so the 32.6% YoY growth headline overstates run-rate stability.
Market and competitive risks are dominated by valuation compression and sector rotation. At 0.99x book the stock is not expensive, but the PS ratio of 6.31x and EV/EBITDA of 20.89x are rich for a lender, and the trailing PE has swung from 34.65x in Q1 2026 to 10.88x today, showing how unstable the earnings base is. The beta of 0.66 limits market-driven drawdowns, but relative strength of -20.34% YTD confirms capital is rotating out of the name even in a rising tape. Recent news flow is a direct threat: Blue Owl cut its base dividend to $0.31 as falling rates squeeze BDC earnings, Blackstone's private credit fund limited redemptions, and commentary explicitly questions what a credit downturn would do to ARCC's payout.
In a worst-case scenario, falling rates compress net investment income further, credit losses rise on middle-market loans, NAV marks down, and management cuts the dividend to protect the balance sheet — triggering yield-driven selling. The realistic downside is a retest of the 52-week low of $17.40, about -7% from $18.72, and a break there could extend toward the 22.1% maximum drawdown, implying a price near $14.58, or roughly -22% from current levels. The analyst low target of $19.00 offers little downside protection because it assumes the dividend holds; a cut would invalidate that anchor entirely.